
Suzuken Co., Ltd.
9987.TJPXHealthcareMedical - Distribution
Latest quote
¥5,086
−¥38.00 · -0.74%
9987.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteSuzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Shigeru Asano
- Listed since
- Jan 1, 2001
- Employees
- 12,717
Market position
Day range
Current ¥5,086
52-week range
Current ¥5,086
- Open
- ¥5,119
- Previous close
- ¥5,124
- Volume
- 89.9K
- 0.45× average
- Average volume
- 200.09K
- Average daily volume
- Market cap
- 344.01B JPY
- Beta
- 0.23
- Market reference 1
- 50-day average
- ¥5,033.28
- +1.05% above average
- 200-day average
- ¥5,719.83
- -11.08% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 9.37×
- P/B (TTM)
- 0.82×
- P/S (TTM)
- 0.14×
- Dividend yield
- 1.97%
Profitability & efficiency
- Gross margin
- 7.63%
- Operating margin
- 1.39%
- Net margin
- 1.50%
Financial health
- Debt / equity
- 0.06×
- Altman Z-score
- 3.11
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 2.49T JPY | 2.4T JPY | 2.39T JPY | 2.31T JPY | 2.24T JPY |
| Cost of goods sold | 2.29T JPY | 2.21T JPY | 2.2T JPY | 2.14T JPY | 2.07T JPY |
| Gross profit | 192.53B JPY | 192.23B JPY | 185.25B JPY | 179.7B JPY | 167.33B JPY |
| Research and development | — | 3.52B JPY | 3.28B JPY | 2.95B JPY | 4.59B JPY |
| Selling, general, and administrative | 156.15B JPY | 151.58B JPY | 147.09B JPY | 144.14B JPY | 142.62B JPY |
| Operating expenses | 156.15B JPY | 155.11B JPY | 150.37B JPY | 147.09B JPY | 147.22B JPY |
| Interest income | 158M JPY | 182M JPY | 166M JPY | 171M JPY | 196M JPY |
| Interest expense | 42M JPY | 41M JPY | 43M JPY | 42M JPY | 51M JPY |
| Depreciation and amortization | 12.34B JPY | 12.06B JPY | 8.74B JPY | 8.84B JPY | 10.02B JPY |
| Operating income | 36.38B JPY | 37.13B JPY | 34.88B JPY | 32.61B JPY | 20.12B JPY |
| Net income | 38.14B JPY | 34.5B JPY | 29.02B JPY | 20.35B JPY | 14.39B JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 73%
- 8 beats, 3 misses, 0 met estimates
- Average EPS surprise
- +55.49%
- 11 comparable reports
- Latest EPS result
- 49.99
- Estimate 69.72 · Miss by 28.30%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
9987.T peers
ETFs holding 9987.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T922.83M0.03%2.89T JPY0.05%¥417.7-0.07%
Vanguard Total International Stock ETFVXUS26.13M0.00%646.2B USD0.05%$87.155-0.63%
Avantis International Small Cap Value ETFAVDV20.85M0.10%20.24B USD0.36%$111.61-0.31%
Vanguard FTSE Developed Markets ETFVEA17.18M0.01%315B USD0.03%$73.055-0.50%
iShares Core MSCI EAFE ETFIEFA13.26M0.01%195.14B USD0.07%$100.65-0.20%
iShares MSCI EAFE Small-Cap ETFSCZ6.37M0.05%13.28B USD0.40%$86.54-0.07%
Schwab Fundamental International Large Company Index ETFFNDF6.37M0.02%26.15B USD0.25%$55.575-0.47%
Dimensional - International Small Cap Value ETFDISV6.31M0.12%5.23B USD0.42%$44.38-0.25%
iShares Core TOPIX ETF1475.T- Market value
- 922.83M
- Weight
- 0.03%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥417.7-0.07%
Vanguard Total International Stock ETFVXUS- Market value
- 26.13M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.155-0.63%
Avantis International Small Cap Value ETFAVDV- Market value
- 20.85M
- Weight
- 0.10%
- AUM
- 20.24B USD
- Expense ratio
- 0.36%
- Price / 1D
- $111.61-0.31%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 17.18M
- Weight
- 0.01%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.055-0.50%
iShares Core MSCI EAFE ETFIEFA- Market value
- 13.26M
- Weight
- 0.01%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.65-0.20%
iShares MSCI EAFE Small-Cap ETFSCZ- Market value
- 6.37M
- Weight
- 0.05%
- AUM
- 13.28B USD
- Expense ratio
- 0.40%
- Price / 1D
- $86.54-0.07%
Schwab Fundamental International Large Company Index ETFFNDF- Market value
- 6.37M
- Weight
- 0.02%
- AUM
- 26.15B USD
- Expense ratio
- 0.25%
- Price / 1D
- $55.575-0.47%
Dimensional - International Small Cap Value ETFDISV- Market value
- 6.31M
- Weight
- 0.12%
- AUM
- 5.23B USD
- Expense ratio
- 0.42%
- Price / 1D
- $44.38-0.25%
Continue in GoAI
Research 9987.Tresearch.disclaimer





